Alerts will be sent to your verified email
Verify Email
ACCPL
|
Accretion Pharma.
|
Sakar Healthcare
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
35.81 % | 9.28 % | 15.1 % |
|
5yr average Equity Multiplier
|
3.8 | 1.75 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
0.96 | 0.5 | 0.82 |
|
5yr Avg Net Profit Margin
|
11.51 % | 10.38 % | 14.59 % |
|
Price to Book
|
4.12 | 2.81 | 1.57 |
|
P/E
|
9.3 | 40.55 | 12.22 |
|
5yr Avg Cash Conversion Cycle
|
102.38 Days | -14.29 Days | -6.41 Days |
|
Inventory Days
|
253.65 Days | 46.75 Days | 43.91 Days |
|
Days Receivable
|
55.55 Days | 51.16 Days | 91.75 Days |
|
Days Payable
|
160.55 Days | 103.34 Days | 128.38 Days |
|
5yr Average Interest Coverage Ratio
|
6.89 | 5.43 | 63.13 |
|
5yr Avg ROCE
|
43.29 % | 10.08 % | 19.81 % |
|
5yr Avg Operating Profit Margin
|
19.95 % | 24.06 % | 18.35 % |
|
5 yr average Debt to Equity
|
1.69 | 0.47 | 0.0 |
|
5yr CAGR Net Profit
|
143.08 % | 3.94 % | 5.76 % |
|
5yr Average Return on Assets
|
11.24 % | 5.37 % | 11.92 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.51 % | 52.86 % | 49.78 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -14.68 % | 5.7 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Accretion Pharma.
|
Sakar Healthcare
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|